PI
ABBV icon

Parkside Investments’s AbbVie ABBV Stock Holding History

Parkside Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,000
Closed -$283K – 104
2018
Q3 		$283K Hold
3,000
– – 0.13% 77
2018
Q2 		$278K Buy
+3,000
New +$293K 0.14% 83

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Parkside Investments's ABBV Position: Q4 2018 in Review

Parkside Investments sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 3,000 shares — an estimated $283K sold.

Parkside Investments first reported a position in ABBV in Q2 2018 and held it in 2 quarters. The position peaked at $283K in Q3 2018. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • Parkside Investments reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
  • Parkside Investments sold 3,000 AbbVie shares in Q4 2018, an estimated $283K.
  • Parkside Investments first reported a position in AbbVie in Q2 2018 and held it in 2 quarters.
  • Parkside Investments's AbbVie position peaked at $283K in Q3 2018.
  • 2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Parkside Investments's 13F filing for Q4 2018, filed 4 Feb 2019.